Short Interest in BioPharma Credit PLC (OTCMKTS:BOPCF) Increases By 1,714.1%

BioPharma Credit PLC (OTCMKTS:BOPCF) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 32,491 shares, a growth of 1,714.1% from the August 15th total of 1,791 shares. Based on an average daily volume of 25,555 shares, the days-to-cover ratio is presently 1.3 days.

BioPharma Credit Price Performance

Shares of OTCMKTS:BOPCF remained flat at $0.93 on Thursday. 21,488 shares of the company’s stock were exchanged, compared to its average volume of 337,758. The business has a 50-day moving average price of $0.96 and a 200-day moving average price of $0.94. BioPharma Credit has a 1-year low of $0.85 and a 1-year high of $1.02.

BioPharma Credit Company Profile

BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.

Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.